Nccih study on reproductive toxicology studies in rats (pots 16-000765)
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $631,772
Award facts
- Opportunity
-
- N02CM4700142 Solicitation number
- Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
- Contract value 100% obligated
- $631,772.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $20,898 | |
| Other Administrative Action | $0 | |
| Original award | $610,874 |
About this award
The National Cancer Institute issued a delivery order to IIT Research Institute on July 27, 2016, with a ceiling value of $631,772, under the Toxicology of Drugs Developed for Cancer Patients IDIQ for reproductive toxicology studies in rats.
Place of performance is Chicago, Illinois. The order runs from July 27, 2016, through March 31, 2018, and is priced on a cost-plus-fixed-fee basis. The work supports preclinical drug development evaluation for cancer therapeutics.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on July 27, 2016.
How much is contract HHSN26100002 worth?
The government has obligated $631,772 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201600015I, an indefinite delivery contract, on Toxicology of Drugs Developed for Cancer Patients.
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award